SJS Investment Consulting’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.8K Sell
130
-137
-51% -$19.7K ﹤0.01% 711
2025
Q4
$38.1K Sell
267
-144
-35% -$19.3K ﹤0.01% 447
2025
Q3
$49.3K Buy
411
+410
+41,000% +$51.9K 0.01% 309
2025
Q2
$133 Sell
1
-1
-50% -$136 ﹤0.01% 1447
2025
Q1
$278 Hold
2
﹤0.01% 1399
2024
Q4
$311 Hold
2
﹤0.01% 1381
2024
Q3
$365 Hold
2
﹤0.01% 1405
2024
Q2
$238 Hold
2
﹤0.01% 1475
2024
Q1
$215 Hold
2
﹤0.01% 1474
2023
Q4
$200 Hold
2
﹤0.01% 1458
2023
Q3
$239 Buy
+2
New +$298 ﹤0.01% 1425
2022
Q1
$0 Buy
+1
New +$224 ﹤0.01% 1001

Other funds holding ICUI

SJS Investment Consulting's ICUI Position: Q1 2026 in Review

SJS Investment Consulting reduced its ICU Medical (ICUI) stake by 51% in Q1 2026, selling an estimated $19.7K and leaving 130 shares worth $16.8K. The position accounts for ﹤0.01% of the portfolio, ranked #711.

SJS Investment Consulting first reported a position in ICUI in Q1 2022 and has held it in 12 quarters since. The position peaked at $49.3K in Q3 2025. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • SJS Investment Consulting held 130 shares of ICU Medical worth $16.8K as of Q1 2026.
  • SJS Investment Consulting sold 137 ICU Medical shares in Q1 2026, an estimated $19.7K.
  • ICU Medical made up ﹤0.01% of SJS Investment Consulting's portfolio in Q1 2026, its #711 holding.
  • SJS Investment Consulting first reported a position in ICU Medical in Q1 2022 and has held it in 12 quarters since.
  • SJS Investment Consulting's ICU Medical position peaked at $49.3K in Q3 2025.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on SJS Investment Consulting's 13F filing for Q1 2026, filed 23 Apr 2026.